Northern Virginia Oral Surgeons Introduce Narcotic-Free Wisdom Teeth Removal
Davary &
A central element of the protocol is EXPAREL®, a long-acting local anesthetic administered at the surgical site during the procedure. According to the manufacturer, EXPAREL® releases medication gradually and may provide targeted pain relief for up to 72 hours following surgery, helping to control discomfort during the critical first days of recovery while reducing the need for additional prescription pain medication.
For appropriate patients, the practice may also incorporate Journavx™ (suzetrigine), an oral non-opioid medication approved by the U.S. Food and Drug Administration in 2025 for the treatment of moderate-to-severe acute pain in adults. Because every procedure and patient is different,
Across medicine and dentistry, surgeons have increasingly emphasized reducing unnecessary opioid prescriptions when effective alternatives are available. Wisdom teeth removal is one of the most common oral surgery procedures, and for many patients it is a first exposure to prescription pain medication. By prioritizing long-acting anesthetics and non-opioid pain control, Davary & Smith aims to support comfortable recoveries while limiting that exposure.
The protocol is delivered within a surgical environment built for safety. Davary & Smith operates one of the few oral surgery centers in
"Many patients and parents tell us their biggest worry isn't the surgery itself—it's leaving with an opioid prescription," said Dr.
"Reducing opioid exposure is one of the most meaningful ways we can protect our patients and their families," added Dr.
More About Davary &
Davary &
Media Contact
Davary &
21351 Gentry Dr STE 115
(703) 972-7773
https://www.davarysmith.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/northern-virginia-oral-surgeons-introduce-narcotic-free-wisdom-teeth-removal-302797648.html
SOURCE Davary &
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Conscientia Health Positions Itself as a National Hybrid Care Platform, Integrating AI to Scale Outcomes-Driven Mental Health and Primary Care
- Nutri.Markets Launches AI-Powered Market Expansion Platform for Consumer Brands in Supplements, Sports Nutrition, Food & Beverage, Skincare, and Cosmetics
- Rocket Lab Awarded $397 Million Contract to Build and Launch Flatellites for U.S. Space Force’s Space-Based Airborne Moving Target Indicator Program
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share